{"id":"hdac-inhibitor-sb939","safety":{"commonSideEffects":[{"rate":"30%","effect":"Fatigue"},{"rate":"20%","effect":"Diarrhea"},{"rate":"15%","effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL5715921","moleculeType":null,"molecularWeight":"652.58"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"SB939 is a potent inhibitor of histone deacetylase enzymes, which play a crucial role in the regulation of gene expression.","oneSentence":"Histone deacetylase inhibitor","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:40:58.789Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Lymphoma"}]},"trialDetails":[{"nctId":"NCT01112384","phase":"PHASE2","title":"A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"2010-10-21","conditions":"Metastatic Sarcoma","enrollment":24},{"nctId":"NCT01184274","phase":"PHASE1","title":"A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"2010-10-01","conditions":"Leukemia, Solid Tumours","enrollment":12},{"nctId":"NCT01075308","phase":"PHASE2","title":"SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"2010-06-28","conditions":"Prostate Cancer","enrollment":32},{"nctId":"NCT00504296","phase":"PHASE1","title":"SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"2007-09-14","conditions":"Unspecified Adult Solid Tumor, Protocol Specific","enrollment":39},{"nctId":"NCT03848754","phase":"PHASE1","title":"Pracinostat and Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2019-05-24","conditions":"Relapsed Adult AML","enrollment":14},{"nctId":"NCT03151408","phase":"PHASE3","title":"An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia","status":"TERMINATED","sponsor":"Helsinn Healthcare SA","startDate":"2017-06-23","conditions":"Acute Myeloid Leukemia","enrollment":406},{"nctId":"NCT03151304","phase":"PHASE2","title":"A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes","status":"TERMINATED","sponsor":"Helsinn Healthcare SA","startDate":"2017-06-01","conditions":"Myelodysplastic Syndromes","enrollment":64},{"nctId":"NCT01912274","phase":"PHASE2","title":"Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)","status":"COMPLETED","sponsor":"Helsinn Healthcare SA","startDate":"2013-12-24","conditions":"Acute Myeloid Leukemia","enrollment":50},{"nctId":"NCT03495934","phase":"PHASE1","title":"A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body","status":"COMPLETED","sponsor":"Helsinn Healthcare SA","startDate":"2018-02-08","conditions":"Healthy Subjects","enrollment":6},{"nctId":"NCT02267278","phase":"PHASE2","title":"Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-01-12","conditions":"Myeloproliferative Diseases","enrollment":25},{"nctId":"NCT01873703","phase":"PHASE2","title":"Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome","status":"COMPLETED","sponsor":"Helsinn Healthcare SA","startDate":"2013-06","conditions":"Myelodysplastic Syndrome","enrollment":102},{"nctId":"NCT02118909","phase":"PHASE1","title":"Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Subjects","status":"COMPLETED","sponsor":"Helsinn Healthcare SA","startDate":"2014-05","conditions":"Healthy Volunteers, Non-smokers","enrollment":32},{"nctId":"NCT01993641","phase":"PHASE2","title":"Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA","status":"COMPLETED","sponsor":"Helsinn Healthcare SA","startDate":"2013-12","conditions":"Myelodysplastic Syndrome, MDS","enrollment":45},{"nctId":"NCT02058784","phase":"EARLY_PHASE1","title":"Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Helsinn Healthcare SA","startDate":"2014-02","conditions":"Healthy Volunteers, Moderate to Heavy Smokers, Non-smokers","enrollment":28},{"nctId":"NCT01200498","phase":"PHASE2","title":"Study of SB939 in Subjects With Myelofibrosis","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-11","conditions":"Myeloproliferative Disorders","enrollment":23},{"nctId":"NCT00741234","phase":"PHASE1","title":"A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine","status":"COMPLETED","sponsor":"S*BIO","startDate":"2007-04","conditions":"Solid Tumors, Hematologic Malignancies, Myelodysplastic Syndrome","enrollment":85}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"HDAC inhibitor SB939","genericName":"HDAC inhibitor SB939","companyName":"NCIC Clinical Trials Group","companyId":"ncic-clinical-trials-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Histone deacetylase inhibitor Used for Lymphoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}